Sandeep Brar

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

David E. Kandzari, Michael Böhm, Felix Mahfoud et al. · The Lancet · 2018 · 776 citations

Medicine, Cardiology, Pharmacology +11

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Michael Böhm, Kazuomi Kario, David E. Kandzari et al. · The Lancet · 2020 · 587 citations

Medicine, Cardiology, Nephrology +8

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

David E. Kandzari, Deepak L. Bhatt, Sandeep Brar et al. · European Heart Journal · 2014 · 540 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

Felix Mahfoud, David E. Kandzari, Kazuomi Kario et al. · The Lancet · 2022 · 282 citations · Full text

Medicine, Cardiology, Nephrology +11

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Deepak L. Bhatt, Muthiah Vaduganathan, David E. Kandzari et al. · The Lancet · 2022 · 176 citations

Medicine, Cardiology, Nephrology +13